Determination of Paclitaxel Distribution in Solid Tumors by Nano-Particle Assisted Laser Desorption Ionization Mass Spectrometry Imaging

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Morosi, Lavinia ^a   Spinelli, Pietro ^a   Zucchetti, Massimo ^a   Pretto, Francesca ^a   Carrà, Andrea ^a   D'Incalci, Maurizio ^a   Giavazzi, Raffaella ^a   Davoli, Enrico ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; PACLITAXEL; TITANIUM DIOXIDE;

ANIMAL TISSUE; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG PENETRATION; FEMALE; HUMAN; HUMAN CELL; KIDNEY; LIVER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MELANOMA; MOLECULAR IMAGING; MOUSE; NONHUMAN; OVARY CARCINOMA; QUANTITATIVE ANALYSIS; SINGLE DRUG DOSE; SOLID TUMOR; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALIBRATION; FEMALE; HUMANS; MASS SPECTROMETRY; MELANOMA; MICE; MICE, NUDE; NANOPARTICLES; PACLITAXEL;

EID: 84883062905     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072532     Document Type: Article

References (44)

1. Seeley EH, Schwamborn K, Caprioli RM, (2011) Imaging of intact tissue sections: moving beyond the microscope. J Biol Chem 286: 25459-25466.
2. Heeren RM, Smith DF, Stauber J, Kukrer-Kaletas B, MacAleese L, (2009) Imaging mass spectrometry: hype or hope? J Am Soc Mass Spectrom 20: 1006-1014.
3. Boggio KJ, Obasuyi E, Sugino K, Nelson SB, Agar NY, et al. (2011) Recent advances in single-cell MALDI mass spectrometry imaging and potential clinical impact. Expert Rev Proteomics 8: 591-604.
4. Reyzer ML, Chaurand P, Angel PM, Caprioli RM, (2010) Direct molecular analysis of whole-body animal tissue sections by MALDI imaging mass spectrometry. Methods Mol Biol 656: 285-301.
5. Lee YJ, Perdian DC, Song Z, Yeung ES, Nikolau BJ, (2012) Use of mass spectrometry for imaging metabolites in plants. Plant J 70: 81-95.
6. Gonzalez DJ, Xu Y, Yang YL, Esquenazi E, Liu WT, et al. (2012) Observing the invisible through imaging mass spectrometry, a window into the metabolic exchange patterns of microbes. J Proteomics 75: 5069-5076.
7. Bunch J, Clench MR, Richards DS, (2004) Determination of pharmaceutical compounds in skin by imaging matrix-assisted laser desorption/ionisation mass spectrometry. Rapid Commun Mass Spectrom 18: 3051-3060.
8. Castellino S, Groseclose MR, Wagner D, (2011) MALDI imaging mass spectrometry: bridging biology and chemistry in drug development. Bioanalysis 3: 2427-2441.
9. Rompp A, Guenther S, Takats Z, Spengler B, (2011) Mass spectrometry imaging with high resolution in mass and space (HR(2) MSI) for reliable investigation of drug compound distributions on the cellular level. Anal Bioanal Chem 401: 65-73.
10. Prideaux B, Dartois V, Staab D, Weiner DM, Goh A, et al. (2011) High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions. Anal Chem 83: 2112-2118.
11. Bouslimani A, Bec N, Glueckmann M, Hirtz C, Larroque C, (2010) Matrix-assisted laser desorption/ionization imaging mass spectrometry of oxaliplatin derivatives in heated intraoperative chemotherapy (HIPEC)-like treated rat kidney. Rapid Commun Mass Spectrom 24: 415-421.
12. Nilsson A, Fehniger TE, Gustavsson L, Andersson M, Kenne K, et al. (2010) Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry. PLoS One 5: e11411.
13. Brignole-Baudouin F, Desbenoit N, Hamm G, Liang H, Both JP, et al. (2012) A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits. PLoS One 7: e50180.
14. Fehniger TE, Vegvari A, Rezeli M, Prikk K, Ross P, et al. (2011) Direct demonstration of tissue uptake of an inhaled drug: proof-of-principle study using matrix-assisted laser desorption ionization mass spectrometry imaging. Anal Chem 83: 8329-8336.
15. Tanaka K, Waki H, Ido Y, Akita S, Yoshida T, et al. (1988) Protien and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry. RCM 2: 151-153.
16. Kinumi T, Saisu T, Takayama M, Niwa H, (2000) Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using an inorganic particle matrix for small molecule analysis. J Mass Spectrom 35: 417-422.
17. Hua Y, Dagan S, Wickramasekara S, Boday DJ, Wysocki VH, (2010) Analysis of deprotonated acids with silicon nanoparticle-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom 45: 1394-1401.
18. Shrivas K, Hayasaka T, Sugiura Y, Setou M, (2011) Method for simultaneous imaging of endogenous low molecular weight metabolites in mouse brain using TiO2 nanoparticles in nanoparticle-assisted laser desorption/ionization-imaging mass spectrometry. Anal Chem 83: 7283-7289.
19. Carra' A, Falciola L, Cappelletti G, Davoli E (2012) Molecular imaging of trace compuonds embedded on human skin by mass specrometry. ASMS 60th annual conference proceedings 1549.
20. Hayasaka T, Goto-Inoue N, Zaima N, Shrivas K, Kashiwagi Y, et al. (2010) Imaging mass spectrometry with silver nanoparticles reveals the distribution of fatty acids in mouse retinal sections. J Am Soc Mass Spectrom 21: 1446-1454.
21. Ugarov MV, Egan T, Khabashesku DV, Schultz JA, Peng H, et al. (2004) MALDI matrices for biomolecular analysis based on functionalized carbon nanomaterials. Anal Chem 76: 6734-6742.
22. Moritake S, Taira S, Sugiura Y, Setou M, Ichiyanagi Y, (2009) Magnetic nanoparticle-based mass spectrometry for the detection of biomolecules in cultured cells. J Nanosci Nanotechnol 9: 169-176.
23. Dupre M, Cantel S, Durand JO, Martinez J, Enjalbal C, (2012) Silica nanoparticles pre-spotted onto target plate for laser desorption/ionization mass spectrometry analyses of peptides. Anal Chim Acta 741: 47-57.
24. Taira S, Sugiura Y, Moritake S, Shimma S, Ichiyanagi Y, et al. (2008) Nanoparticle-assisted laser desorption/ionization based mass imaging with cellular resolution. Anal Chem 80: 4761-4766.
25. Amstalden van Hove ER, Blackwell TR, Klinkert I, Eijkel GB, Heeren RM, et al. (2010) Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models. Cancer Res 70: 9012-9021.
26. Minchinton AI, Tannock IF, (2006) Drug penetration in solid tumours. Nat Rev Cancer 6: 583-592.
27. Marko-Varga G, Fehniger TE, Rezeli M, Dome B, Laurell T, et al. (2011) Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging. J Proteomics 74: 982-992.
28. Cornett DS, Frappier SL, Caprioli RM, (2008) MALDI-FTICR imaging mass spectrometry of drugs and metabolites in tissue. Anal Chem 80: 5648-5653.
29. Atkinson SJ, Loadman PM, Sutton C, Patterson LH, Clench MR, (2007) Examination of the distribution of the bioreductive drug AQ4N and its active metabolite AQ4 in solid tumours by imaging matrix-assisted laser desorption/ionisation mass spectrometry. Rapid Commun Mass Spectrom 21: 1271-1276.
30. Rowinsky EK, Donehower RC, (1995) Paclitaxel (taxol). N Engl J Med 332: 1004-1014.
31. Thigpen T, duBois A, McAlpine J, DiSaia P, Fujiwara K, et al. (2011) First-line therapy in ovarian cancer trials. Int J Gynecol Cancer 21: 756-762.
32. van der Burg ME, Vergote I, Onstenk W, Boere IA, Leunen K, et al. (2012) Long-term results of weekly paclitaxel carboplatin induction therapy: An effective and well-tolerated treatment in patients with platinum-resistant ovarian cancer. Eur J Cancer.
33. Katsumata N, (2011) Dose-dense therapy is of benefit in primary treatment of ovarian cancer? In favor. Ann Oncol 22Suppl 8: viii29-viii32.
34. Taghian AG, Abi-Raad R, Assaad SI, Casty A, Ancukiewicz M, et al. (2005) Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implications. J Clin Oncol 23: 1951-1961.
35. Griffon-Etienne G, Boucher Y, Brekken C, Suit HD, Jain RK, (1999) Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Cancer Res 59: 3776-3782.
36. Silini A, Ghilardi C, Ardinghi C, Bernasconi S, Oliva P, et al. (2010) Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype. Clin Exp Metastasis 27: 43-53.
37. Bani MR, Nicoletti MI, Alkharouf NW, Ghilardi C, Petersen D, et al. (2004) Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts. Mol Cancer Ther 3: 111-121.
38. Li L, Sillanpaa M, Tuominen M, Lounatmaa K, Schultz E (2012) Behavior of titanium dioxide nanoparticles in Lemna minor growth test conditions. Ecotoxicol Environ Saf.
39. Stoeckli M, Staab D, Schweitzer A, Gardiner J, Seebach D, (2007) Imaging of a beta-peptide distribution in whole-body mice sections by MALDI mass spectrometry. J Am Soc Mass Spectrom 18: 1921-1924.
40. Sottani C, Minoia C, D'Incalci M, Paganini M, Zucchetti M, (1998) High-performance liquid chromatography tandem mass spectrometry procedure with automated solid phase extraction sample preparation for the quantitative determination of paclitaxel (Taxol) in human plasma. Rapid Commun Mass Spectrom 12: 251-255.
41. Armirotti A BU, Miele M, Damonte G, (2005) Matrix-assisted laser desorption/ionization mass spectrometry of taxanes. Rapid Commun Mass Spectrom 19(23): 3531-3538.
42. Troendle FJ RC, Yost RA, (1999) Detection of pharmaceutical compounds in tissue by matrix-assisted laser desorption/ionization and laser desorption/chemical ionization tandem mass spectrometry with a quadrupole ion trap. Journal of the American Society for Mass Spectrometry 10: 1315-1321.
43. Carrà A FL, Cappelletti G, Davoli E (2012) Molecular imaging of trace compuonds embedded on human skin by mass specrometry. ASMs 60th annual conference proceedings 1549.
44. Moschetta M, Pretto F, Berndt A, Galler K, Richter P, et al. (2012) Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin-positive metastatic human melanoma xenografts. Cancer Res 72: 1814-1824.